IDL Diagnostics AB (publ) (STO:IDLDX)

IDL Diagnostics AB Cash Flow Statement

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-44.27	-42.45	-59.3	-58.97	-50.03	-24.05
Depreciation & Amortization	43.18	43.18	45.54	47.18	20.31	0.32
Other Amortization	-	-	-	-	4.27	4.27
Other Operating Activities	4.09	-0.84	0.7	-0.53	-0.34	-
Change in Accounts Receivable	-4.23	-4.23	1.03	-4.27	-1.17	0.25
Change in Inventory	0.34	0.34	-0.12	-0.47	0.06	0.06
Change in Accounts Payable	1.01	1.01	-2.92	-	-	-
Change in Other Net Operating Assets	0.64	0.64	1.63	3.36	-1.3	0.24
Operating Cash Flow	0.74	-2.36	-13.44	-13.69	-28.21	-18.9
Capital Expenditures	-0.14	-0.14	-0.5	-3.02	-	-0.05
Cash Acquisitions	-	-	-	-6.06	4.91	-
Sale (Purchase) of Intangibles	-0.44	-0.44	-0.78	-1.03	-0.37	-
Other Investing Activities	-0.04	-	-0	-0	-	-
Investing Cash Flow	-0.62	-0.58	-1.28	-10.12	4.54	-0.05
Issuance of Common Stock	-	-	0.25	86.81	-	54.43
Other Financing Activities	-	-	-	-16.21	-	-7.09
Financing Cash Flow	-	-	0.25	70.6	-	47.34
Miscellaneous Cash Flow Adjustments	-	-	-	-0	-	-
Net Cash Flow	0.12	-2.94	-14.47	46.79	-23.66	28.38
Free Cash Flow	0.6	-2.5	-13.93	-16.72	-28.21	-18.96
Free Cash Flow Margin	1.01%	-4.35%	-32.38%	-45.20%	-235.13%	-22565.48%
Free Cash Flow Per Share	0.00	-0.01	-0.06	-0.08	-0.30	-0.26
Cash Interest Paid	0	0	0.01	-	-	-
Cash Income Tax Paid	0.84	0.84	-0.66	0.2	-0.25	-
Levered Free Cash Flow	17.05	11.64	8.46	3.97	-12.82	-16.89
Unlevered Free Cash Flow	17.05	11.65	8.47	3.97	-12.82	-16.89
Change in Net Working Capital	-3	3.08	-1.71	1.58	5.27	6.44

Source: S&P Global Market Intelligence. Standard template. Financial Sources.